secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunovant, Inc. (IMVT)
CIK:        0001764013
Form:       8-K
Filed at:   2022-08-19T23:59:59+00:00
Accession:  0001764013-22-000108
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Immunovant stockholders elect directors, ratify auditor, approve say-on-pay at 2022 annual meeting
--------------------------------------------------------------------------------

- Three directors elected: Peter Salzmann, Douglas Hughes, George Migausky — all with >90M votes for.
- Ernst & Young LLP ratified as independent auditor for FY ending March 31, 2023 (105.8M for, 33k against).
- Non-binding advisory approval of named executive officer compensation passed with 87.5M for, 14.8M against.
- Approximately 91% of shares entitled to vote were represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1764013/000176401322000108/0001764013-22-000108-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1764013/000176401322000108/imvt-20220817x8xk.htm
  HTML page:      https://secwatch.observer/filing/0001764013-22-000108

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer